Cystic Fibrosis (CF) Therapeutics Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Cystic Fibrosis (CF) Therapeutics Market Growth in 2025?
In recent years, there has been a substantial growth in the market size of cystic fibrosis (CF) therapeutics. The market is set to grow from $7.54 billion in 2024 to $8.31 billion in 2025, yielding a compound annual growth rate (CAGR) of 10.2%. Factors such as advancements in targeted therapy, increased comprehension of CF genetics, heightened patient advocacy and awareness, governmental backing for research, entitlement to orphan drug status, and incentives to rare disease research are responsible for the observed growth during the historical period.
What Is the Forecast for the Cystic Fibrosis (CF) Therapeutics Market Size Through 2029?
The market size for cystic fibrosis (CF) therapeutics is predicted to experience a significant increase in the coming years, expected to reach $11.42 billion in 2029 with a compound annual growth rate (CAGR) of 8.3%. The projected growth during this forecast period can be traced back to an increase in the CF patient population, approval of novel therapies by regulatory bodies, a shift towards personalized medicine, a rise in biomarker research investment, growth in newborn screening programs, and supportive healthcare policies. Key trends anticipated to shape the forecast period involve the expansion of CFTR modulators, the application of gene-editing technologies, strategies for early intervention, the advancement in diagnostic techniques, the use of telehealth and remote monitoring, the digitalization of healthcare, and the management of chronic diseases.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9056&type=smp
What are the Key Market Players in Cystic Fibrosis (CF) Therapeutics Market and How They’re Evolving?
Major companies operating in the cystic fibrosis (CF) therapeutics market include Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Pharmaxis, Bayer AG, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc, ProQR Therapeutics N.V., Enterprise Therapeutics Ltd. , Corbus Pharmaceuticals Holdings Inc, Eloxx Pharmaceuticals , Translate Bio Inc, Zambon S.p.A
What Are the Primary Growth Drivers in the Cystic Fibrosis (CF) Therapeutics Market?
The cystic fibrosis (CF) therapeutics market is predicted to experience expansion, propelled by an uptick in cystic fibrosis patients. Cystic fibrosis is a genetically inherited malady that significantly damages the lungs, digestive system, and various other organs of the body. Therapeutics for cystic fibrosis are employed to alleviate the disease’s symptoms by thinning the mucus in the lungs, making it easy to cough up. Consequently, this increase in cystic fibrosis patients is anticipated to stimulate the CF therapeutics market’s growth. For example, a report issued by The Cystic Fibrosis Foundation, a non-profit organization based in the US, stated an upswing in cystic fibrosis instances in July 2022. The report reveals that cystic fibrosis impacts close to 40,000 children and adults in the United States in 2022 alone, and a worldwide diagnosis exceeding 105,000 individuals. Therefore, this rise in cystic fibrosis patients is propelling the CF therapeutics market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9056&type=smp
What Are the Leading Segments in the Global Cystic Fibrosis (CF) Therapeutics Industry?
The cystic fibrosis (CF) therapeutics market covered in this report is segmented –
1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators
2) By Route Of Administration: Oral, Inhaled
3) By Treatment Method: Medication, Devices
Subsegments:
1) By Pancreatic Enzyme Supplements: Lipase, Amylase, Protease
2) By Mucolytics: Dornase Alfa (Pulmozyme), Hypertonic Saline
3) By Bronchodilators: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Anticholinergics
4) By CFTR Modulators: Ivacaftor, Lumacaftor Or Ivacaftor (Orkambi), Tezacaftor Or Ivacaftor (Symdeko), Elexacaftor Or Tezacaftor Or Ivacaftor
What Are the Key Market Trends in the Cystic Fibrosis (CF) Therapeutics Industry?
Prominent companies active in the cystic fibrosis (CF) therapeutics market are introducing novel solutions for treatment and patient care, such as the cystic fibrosis innovation hub network, in an effort to speed up research, elevate treatment alternatives, and fortify collaboration in creating new therapies for CF patients. The innovation hub network for cystic fibrosis is designed as a cooperative platform or initiative with the purpose of hastening the research and development of CF treatments. In October 2024, one example of this initiative was seen when LifeArc, a UK-based charity and life sciences company dedicated to transforming scientific research into practical healthcare solutions, inaugurated the UK’s inaugural Cystic Fibrosis Innovation Hub Network. This network aims to boost research and development for CF treatment methods. It supports teamwork between healthcare providers, researchers, and patients. Launched with the broader aim of facilitating innovation in cystic fibrosis therapies, the hub zeroes in on identifying novel drug development routes and enhancing patient outcomes.
Access The Full Report Here:
What Is the Regional Outlook for the Cystic Fibrosis (CF) Therapeutics Market?
North America was the largest region in the cystic fibrosis (CF) therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cystic fibrosis (CF) therapeutics market during the forecast period. The regions covered in the cystic fibrosis (CF) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9056
This Report Delivers Insight On:
1. How big is the cystic fibrosis (cf) therapeutics market, and how is it changing globally?
2. Who are the major companies in the cystic fibrosis (cf) therapeutics market, and how are they performing?
3. What are the key opportunities and risks in the cystic fibrosis (cf) therapeutics market right now?
4. Which products or customer segments are growing the most in the cystic fibrosis (cf) therapeutics market?
5. What factors are helping or slowing down the growth of the cystic fibrosis (cf) therapeutics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
